ALMSのPER（株価収益率）は？

ALUMIS INC（ALMS）は現在PER 62.22倍で取引されています。

ALMSのROE（自己資本利益率）は？

ALUMIS INCのROEは-41.87%です。

ALMSの配当利回りは？

ALUMIS INCの配当利回りは0.00%です。

ALMSの品質スコア（Quality Score）は？

当社のAIはALMSの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ALMSは今が買い時ですか？

当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ALMSはどのセクターに属しますか？

ALUMIS INCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

ALMS (NASDAQ) 株価分析 | ALUMIS INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ALMS AI Analysis Summary

Our AI summary for ALMS: ALUMIS INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 62.22, ROE of -41.87%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ALMS

ALUMIS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 96

USD 28.25

-0.70 (-2.42%) Day Change

Watchlist Portfolio Compare Chart

62.22

P/E

0.01

D/E

-41.9%

ROE

-35.4%

ROA

0.00%

Div Yield

2.66

PEG

ALUMIS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 28.25 Price -0.70 (-2.42%) Day Change	NEWS SCORE: 96

ALMS, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAがROEに比べて低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Deepscope 分析

39%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	96
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	28.25
PBV / Sector	6.51 / 5.20
Earning Per Share	-1.82

PE / Sector	62.22 / 19.97
PEG or PE/Growth / Sector	2.66 / 1.22
Average 1M Daily Value	35.97 M GREAT
Average 1W Daily Value	26.95 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-2,825.70 / 98.71
NPM Average (%) / Sector	-1,918.72 / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-35.35 / 27.02
ROA Average (%) / Sector	-91.43 / -368.17
ROA Change Average (%) / Sector	-13.67 / 5,404.12
ROE (%) / Sector	-41.87 / 3.47
ROE Average (%) / Sector	-26.55 / 6.51
ROE Change Average (%) / Sector	-111.17 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 07:59:27
Symbol	ALMS
Name	ALUMIS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	123.43 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	3,690.89 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 280 East Grand Avenue, South San Francisco, CA, United States, 94080

Phone: 650 231 6625

Website: https://www.alumis.com

Employees: 225

Sector: Healthcare >> Biotechnology

Description: Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company offers envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor that is in Phase 1 for the treatment of neuroinflammatory and neurodegenerative diseases. It also develops lonigutamab, a monoclonal antibody targeting IGF-1R for the treatment of thyroid eye diseases; and interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. Alumis Inc. was incorporated in 2021 and is headquartered in South San Francisco, California.